Delcath Systems

Delcath Systems Working Capital

The Working Capital of Delcath Systems (DCTH) as of Oct 28, 2026 is 95.64 M USD. In the previous year, Working Capital was 62.43 M USD — a change of 53.19% (higher).

Working Capital

95.64 MUSD

YoY

53.19%

Last updated:

Working Capital of Delcath Systems is 2025 95.64 M USD. Working Capital of Delcath Systems was 2024 62.43 M USD. It decreases by 53.19% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Working Capital of Delcath Systems is 95.64 M USD in 2025.

Working Capital of Delcath Systems changed from 62.43 M USD to 95.64 M USD, representing a 53.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Delcath Systems historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Delcath Systems

All Key Metrics — Delcath Systems